Other news

u-card-img-1
News

Launch of the 2021 WELBIO Investigator Programme call!

The FRFS-WELBIO announces its 2021 call for "WELBIO Investigator programmes" for basic research in the fields of life sciences that can lead to applications in all fields of (bio)technology.

Learn more
u-card-img-1
News
Prix Quinquennaux FNRS 2020

Prix scientifique Joseph Maisin à Jean-François Collet

Le Prix Joseph Maisin en Sciences biomédicales fondamentales 2020 a été attribué à Jean-François Collet (WELBIO - UCLouvain) lors d’une cérémonie en présence de Sa Majesté le Roi.

Learn more
u-card-img-1
News
Publication in Molecular Cell

A magic alarmone to rescue hungry bacteria

Abel Garcia-Pino (WELBIO – ULB) and his team shed light on the role played by  alarmone for induction of the synthetic activity of E. coli RelA by starved ribosomes.

Learn more
u-card-img-1
News
Publication in Molecular Cell

An old fold can learn new tricks

Abel Garcia-Pino (WELBIO – ULB) and his team uncovered the mechanism of toxicity used by the toxin-antitoxin systems (toxSAS) in bacteria.

Learn more
u-card-img-1
News

2020 Annual report

2020 marks the 10th anniversary of our first call for projects! Learn about our researchers, their scientific advances and how some of their discoveries have been translated into applications for human health.

Learn more
u-card-img-1
News
Publication in Nature Cancer

RNA epigenetics as a key regulator of cancer metastasis

François Fuks (WELBIO – ULB) and his team demonstrated the role of the regulation of RNA epigenetics by the FTO enzyme in the development of cancer metastasis.

Learn more
u-card-img-1
News
Spin-off creation

NeuVasQ: An innovative approach to fight against neurovascular and neurodegenerative diseases

From disruptive research of scientific founder Benoit Vanhollebeke (WELBIO - ULB) to the development of blood-brain barrier pharmaceuticals aiming at repairing neurovascular function and neurodegenerative diseases.

Learn more
u-card-img-1
News
Publication in Gut

D. welbionis : potential implications for metabolic diseases

A new bacterium, made in Belgium

Patrice Cani (WELBIO - UCLouvain) describes the properties displayed by D. welbionis, a new bacterium present in 70% of the population, that open the doors for potential treatment for type 2 diabetes, obesity and inflammatory diseases.

Learn more
u-card-img-1
News
Publication in Nature Communications

Wobble transfer RNA modifications optimize dynamic proteome expression

Pierre Close (WELBIO – ULiège) and Francesca Rapino describe how the regulation of transfer RNAs and modification of their anticodon impact the dynamics of protein synthesis and regulate protein folding and stability.

Learn more
u-card-img-1
News
Publication dans Science Advances

Maladies auto-immunes, des signatures moléculaire similaires au niveau des tissus cibles ?

L'utilisation d'inhibiteurs de TYK2 - déjà utilisés pour d'autres maladies auto-immunes - protège les cellules β contre les dommages induits par le système immunitaire

Decio Eizirik (WELBIO - ULB) et son équipe décrivent des signatures moléculaires similaires entre différentes maladies auto-immunes, identifiant des voies clés qui pourraient être ciblées pour la thérapie.

Learn more
u-card-img-1
News
Publication in Nature

Cancer: Tumor driver promoting EMT, metastasis and resistance to therapy

New therapy for FAT1 mutated cancers

Cédric Blanpain (WELBIO – ULB) and his team identify the functions of FAT1, one of the most frequently mutated cancer gene drivers, uncovering that FAT1 mutations promote invasive features, metastasis and resistance to commonly used anti-cancer drugs

Learn more
u-card-img-1
News
The "Belgian Nobel Prize"

The Francqui-Collen Prize 2020 is awarded to Cédric Blanpain

Prize awarded to a Belgian investigator less than 50 y.o. “who has made an important contribution to science augmenting the prestige of Belgium".”

Director of the Laboratory of Stem Cells and Cancer (ULB), WELBIO investigator, Pr. Cédric Blanpain is awarded the Francqui-Collen Prize for his fundamental research in cancer and stem cells biology.

Learn more

Share this page